ARKK Daily Position Changes Report for February 10, 2026
Overview
On February 10, 2026, the ARK Innovation ETF (ARKK) exhibited notable trading activity, particularly with significant changes in several key holdings. The fund has made strategic adjustments, including new positions and modifications to existing ones.
Detailed Summary
The analysis of holdings between February 9 and February 10 reveals that ARKK added a new position in Archer Aviation Inc-A (ACHR), while also increasing its stakes in Beam Therapeutics Inc (BEAM) and Tesla Inc (TSLA). Conversely, the fund reduced its positions in several other holdings, including CRISPR Therapeutics AG (CRSP), Tempus AI Inc-A (TEM), and Shopify Inc (SHOP). The overall portfolio weight changes reflect a strategic shift towards companies that ARK Invest believes have higher growth potential, while trimming positions in those that may not align with current investment theses.
Position Changes Table
| Ticker | Company Name | Direction | Shares Traded | Estimated Trade Value ($) | % of Portfolio Change |
|---|---|---|---|---|---|
| ACHR | Archer Aviation Inc-A | Buy | 10,043,041.61 | 70,000,000.00 | 1.000 |
| BEAM | Beam Therapeutics Inc | Buy | 2,183,654.06 | 56,753,168.96 | 0.043 |
| TSLA | Tesla Inc | Buy | 61,909.48 | 26,513,971.42 | -0.197 |
| TWST | Twist Bioscience Corp | Sell | -405,298.59 | 20,119,021.81 | 0.273 |
| SHOP | Shopify Inc-A | Sell | -118,178.65 | 14,028,987.50 | -0.300 |
| ROKU | Roku Inc-A | Sell | -145,149.56 | 12,757,194.61 | 0.165 |
| TEM | Tempus AI Inc-A | Sell | -234,010.01 | 12,545,276.54 | -0.328 |
| CRSP | CRISPR Therapeutics AG | Sell | -201,916.10 | 9,756,585.96 | -0.163 |
| COIN | Coinbase Global Inc-A | Buy | 7,869.86 | 1,205,662.23 | -0.298 |
| PLTR | N/A | Sell | -3,336.92 | 452,752.74 | -0.228 |
Analysis and Interpretation
The addition of Archer Aviation Inc-A (ACHR) signifies ARK Invest's continued focus on innovative technologies in the aviation sector. The increases in Tesla (TSLA) and Beam Therapeutics (BEAM) suggest confidence in their growth trajectories, despite recent market volatility.
On the other hand, the reductions in holdings such as CRISPR (CRSP) and Shopify (SHOP) may indicate a reevaluation of their potential in the current market landscape, possibly due to performance concerns or shifts in market sentiment.
The overall strategy appears to be one of consolidation around high-potential stocks while taking profits or reducing exposure in others that may not meet ARK's investment criteria going forward.
This report provides a snapshot of ARKK's strategic positioning as of February 10, 2026, reflecting the fund's dynamic approach to investment management.
Explore more exclusive insights at nextfin.ai.
